✦ LIBER ✦

The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer

✍ Scribed by Tripathy, Debu; Rugo, Hope S; Kaufman, Peter A; Swain, Sandra; O’Shaughnessy, Joyce; Jahanzeb, Mohammad; Mason, Ginny; Beattie, Mary; Yoo, Bongin; Lai, Catherine; Masaquel, Anthony; Hurvitz, Sara

Book ID: 125398947
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 345 KB
Volume: 14
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-14-307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment patterns and clinical outcomes

Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study

✍ Peter A. Kaufman,Adam M. Brufsky,Musa Mayer… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 268 KB

Impact of hormone receptor status on pat

Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study

✍ Ines Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, P Kelly Marcom, Beverly Moy, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 377 KB

Phase II Randomized Study of Trastuzumab

Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer

✍ Hurvitz, S. A.; Dirix, L.; Kocsis, J.; Bianchi, G. V.; Lu, J.; Vinholes, J.; Gua 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 205 KB

The Prognostic Significance of Human Epi

The Prognostic Significance of Human Epidermal Growth Factor Receptor-2 (HER2) Positivity and Breast Cancer Subtype in Patients (PTS) with Microinvasive Breast Cancer (MIBC)

✍ D.N. Margalit; J.E. Brock; M. Sreedhara; Y. Chen; P.J. Catalano; P.L. Nguyen; J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Overall Survival Benefit With Lapatinib

Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study

✍ Blackwell, K. L.; Burstein, H. J.; Storniolo, A. M.; Rugo, H. S.; Sledge, G.; Ak 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 203 KB

Feasibility and pharmacokinetics of comb

Feasibility and pharmacokinetics of combined therapy with S-1 and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic or recurrent breast cancer

✍ Suzuki, Yasuhiro; Ogiya, Rin; Oshitanai, Risa; Terao, Mayako; Terada, Mizuho; Mo 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 288 KB